Members of the T cell immunoglobulin-and mucin-domain-containing molecule (TIM) family have roles in T cell-mediated immune responses. TIM-1 and TIM-2 are predominantly expressed on Th2 cells, whereas TIM-3 is preferentially expressed on Th1 and Th17 cells. We found that TIM-1 and TIM-3, but neither TIM-2 nor TIM-4, were constitutively expressed on mouse peritoneal mast cells and bone-marrow-derived cultured mast cells (BMCMCs). After IgE+Ag stimulation, TIM-1 expression was downregulated on BMCMCs, whereas TIM-3 expression was upregulated. We also found that recombinant mouse TIM-4 (rmTIM-4), which is a ligand for TIM-1, as well as an anti-TIM-3 polyclonal Ab, can promote IL-4, IL-6 and IL-13 production without enhancing degranulation in BMCMCs stimulated with IgE+Ag. Moreover, the anti-TIM-3
Introduction
Molecules of the TIM family are thought to contribute to the development of autoimmune and allergic diseases by modulating T cell function [1] [2] [3] [4] , and genetic polymorphism affecting these molecules may also play a role in such disorders [1] [2] [3] [4] . TIM-1 enhances and TIM-2 suppresses Th2 cell activation, and TIM-3 down regulates Th1 cell function [1] [2] [3] . Such effects are likely to be important. Thus, mice treated with an anti-TIM-1
Ab or a TIM-1 extracellular domain protein exhibited attenuated development of antigen-induced airway inflammation 5 and of contact or delayed-type hypersensitivity responses 6 ; administration of TIM-2-Ig to mice ameliorated development of experimental autoimmune encephalomyelitis 7 while TIM-2-deficient mice exhibited exacerbated airway inflammation 8 ; and blockade of the TIM-3 pathway exacerbated experimental autoimmune encephalomyelitis 9 , diabetes (in nonobese diabetic mice) 10 and acute graft-vs-host disease 11 .
Mast cells are important effector cells in host defense, and also contribute to the development of autoimmune and allergic diseases 12 . In this study, we examined mouse mast cells for expression of TIM family members and investigated whether such TIM expression by mast cells is functionally significant. 
Study Design
Animal protocols were approved by the Stanford Administrative Panels on Laboratory Animal Care.
Mice and BMCMCs.
C57BL/6J and BALB/cJ mice, and C57BL/6Ka and BALB/cKa mice, were from the Jackson Laboratories and the Stanford Animal Facility, respectively. BMCMCs were obtained by culturing mouse bone marrow cells in WEHI-3 conditioned medium (containing IL-3) for 4-6 weeks, at which time >98% of the cells were identified as mast cells by flow cytometry for c-Kit and FcεRI.
Reagents and Abs.
rmIL-3, rmTIM-1, rmTIM-4, mouse mAbs for TIM-1 (222414) and TIM-3 (215015) and polyclonal Abs (pAbs) for TIM-1,TIM-3 and TIM-4 were from R&D systems. Anti-mouse TIM-3 mAb (8B.2C12), mTIM-1-Ig and mTIM-3-Ig were from eBioscience. Anti-mouse TIM-1 (RMT1-4 and RMT1-17), TIM-2 (RMT2-1 and RMT2-14) (Fig. S1 ) and TIM-3 (RMT3-23) 11 mAbs (currently available from eBioscience or BioLegend) were from H. A. Anti-mouse TIM-1 (3B3) 13 and TIM-4 (21H12) ( were not appropriate for Western blot analyses (Fig. S3 ). 15 and β-hexosaminidase release assay 16 were performed as described.
We used the Apoptosis Detection Kit and Bcl-2 Set (BD PharMingen) for annexin V staining and Bcl-2 expression. Cytokine levels in supernatants were measured by Mouse IL-3, IL-4 and IL-6 BD OptEIA™ ELISA sets (BD PharMingen) and Mouse IL-13 DuoSets (R&D systems).
Statistics.
The unpaired Student's t-test, 2-tailed, was used for statistical evaluation of the results; unless otherwise specified, results are shown as mean + SD (n = 3/group).
Results and Discussion
Expression of TIM family members on mouse mast cells.
TIM molecules exhibit splicing variants in several mouse strains [1] [2] [3] . We therefore evaluated the expression of TIM family members using different mAbs for TIMs. Naïve BMCMCs from C57BL/6J mice constitutively expressed TIM-1, as detected by anti-TIM-1 mAbs (3B3, RMT1-4 or RMT1-17) ( Figure 1A ). TIM-1 expression appeared to be slightly decreased 6 h after IgE+Ag TIM-1 and TIM-3 can enhance mast cell-Th2 cytokine production.
Interactions between TIM-1 on Th2 cells and TIM-4 on DCs can enhance Th2 cell function 13, 18 ,
whereas administration of anti-TIM-1 Ab attenuated a Th2-associated mouse model of allergic airway inflammation 5 . We searched for effects of TIMs on degranulation and/or Th2-associated cytokine production in naïve, IgE-sensitized or IgE-sensitized and Ag-stimulated BMCMCs.
Neither Anti-TIM-3 pAb also promoted IL-3 production, but not Bcl-2 expression, in BMCMCs ( Figure   2G , I and H).
Results similar to those in Figure 2 were also obtained in BALB/cJ BMCMCs (data not shown). Our results are consistent with results of in vivo studies [9] [10] [11] , in which anti-TIM-3 mAbs (RMT3-23 or 8B.2C12) functioned as blocking Abs whereas anti-TIM-3 pAb had agonist effects.
Our data demonstrate that mouse mast cells can constitutively express TIM-1 and TIM-3, but do not detectably express TIM-2 or TIM-4. Moreover, in contrast to evidence that TIM-3 can negatively regulate Th1 cells, our findings indicate that, in mast cells, TIM-3 can enhance IgE+Ag-dependent cytokine secretion and survival. These observations raise the possibility that TIM-1 and/or TIM-3 can influence the development of autoimmune and allergic disorders at least in part through effects on mast cells.
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